Back

Therapeutic synergy between drugs, devices and interventions.

26 May 2019 (09:15 - 09:30)
Organised by:
Congress Presentation Part of: Functional mitral regurgitation: the road ahead. Valvular Heart Disease HFA Premium Access Heart Failure 2019

About the speaker

Photo
Professor Frank Ruschitzka

University Hospital Zurich, Zurich (Switzerland)

4 More presentations in this session

Presentation thumbnail
Transcatheter mitral interventions: indications and controversies.
Professor P. Ponikowski (Wroclaw, PL)
Slides Video
Presentation thumbnail
MITRA-FR trial: facts and perspectives.
Professor N. Mewton (Lyon, FR)
Slides Video
Presentation thumbnail
What can we learn from COAPT trial?
Professor J. Lindenfeld (Nashville, US)
Slides Video
Presentation thumbnail
Panel discussion: the road ahead.
Video

Access the full session

Session thumbnail
Functional mitral regurgitation: the road ahead.

The Event

Event poster

Heart Failure 2019

26 May 2019 09:15 CET
You may be interested in
thumbnail
Webinar
New 2021 HF guidelines - what is new for device therapies and how to optimally combine new HF drugs with ICD-CRTDs
16 February 2023
thumbnail
Congress Presentation
COMBINE Angina: 1st study showing the benefits of combination therapy in recently diagnosed chronic coronary syndrome patients
31 August 2025
thumbnail
Congress Presentation
The impact of non-pharmacological therapies on cardiovascular outcomes in patients with refractory angina: a systematic review and meta-analysis of randomized controlled trials
27 August 2021
thumbnail
Congress Session
Innovative drug therapies in heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources